# A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

> **NCT01268527** · PHASE2 · COMPLETED · sponsor: **Eisai Limited** · enrollment: 30 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** 0.03% E6201
- **DRUG:** 0.1% E6201
- **DRUG:** 0.2% E6201
- **DRUG:** 0.005% E6201
- **DRUG:** 0.01% E6201
- **DRUG:** 0.05% E6201
- **OTHER:** Placebo - 0.03% gel vehicle
- **OTHER:** Placebo - 0.1% gel vehicle
- **OTHER:** Placebo - 0.2% gel vehicle
- **OTHER:** Placebo - 0.05% gel vehicle
- **OTHER:** Placebo - 0.01% gel vehicle
- **OTHER:** Placebo - 0.05% gel vehicle
- **DRUG:** Calcipotriene

## Key facts

- **NCT ID:** NCT01268527
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-15
- **Primary completion:** 2010-12-11
- **Final completion:** 2010-12-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01268527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01268527, "A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01268527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*